Changeflow GovPing Healthcare GEM Premier 5000 PAK Recall - PCSND Errors
Urgent Enforcement Removed Final

GEM Premier 5000 PAK Recall - PCSND Errors

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has issued a Class II recall for Instrumentation Laboratory's GEM Premier 5000 PAK (Part No. 00055407504) due to Process Control Solution Not Detected (PCSND) errors. The recall affects worldwide distribution, including the US.

What changed

The FDA has initiated a Class II device recall for GEM Premier 5000 PAKs (Part No. 00055407504) manufactured by Instrumentation Laboratory. The recall is prompted by confirmed customer complaints indicating an increased incidence of Process Control Solution Not Detected (PCSND) errors during the warm-up phase, which can lead to GEM PAK ejection. This issue necessitates the insertion of new cartridges.

This recall impacts worldwide distribution, including the United States and several other countries. Healthcare providers using the GEM Premier 5000 system should be aware of this potential malfunction and follow manufacturer instructions for addressing PCSND errors and cartridge replacement. While no specific compliance deadline is listed, the ongoing nature of the recall implies immediate attention is required for affected devices.

What to do next

  1. Review device usage for PCSND errors
  2. Follow manufacturer guidance for cartridge replacement
  3. Report any adverse events related to this recall

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1528-2026 · 20260318 · Ongoing

Product

GEM Premier 5000 PAK; Part No. 00055407504.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1528-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Recalls
Geographic scope
United States US

Taxonomy

Primary area
Product Safety
Operational domain
Compliance
Topics
Medical Devices Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.